SCHEDULE: Citadel Discloses 6.2% Stake in Nano Labs Ltd
Beneficial Ownership Disclosure
Citadel entities and Kenneth Griffin have disclosed a combined 6.2% beneficial ownership stake in Nano Labs Ltd, primarily through Class A ordinary shares and convertible warrants.
Summary
- Citadel Advisors LLC, Citadel Advisors Holdings LP, Citadel GP LLC, Citadel Securities LLC, Citadel Securities Group LP, Citadel Securities GP LLC, and Kenneth Griffin (collectively, the "Reporting Persons") have filed an Amendment No. 1 to Schedule 13G for Nano Labs Ltd.
- The filing reports beneficial ownership of Nano Labs Ltd's Class A ordinary shares, par value US$0.002 per share.
- Kenneth Griffin, through his control of the various Citadel entities, beneficially owns an aggregate of 1,360,572 shares, representing 6.2% of the outstanding Class A ordinary shares.
- Citadel Advisors LLC, Citadel Advisors Holdings LP, and Citadel GP LLC each beneficially own 1,300,000 shares, constituting 5.9% of the class.
- Citadel Securities LLC, Citadel Securities Group LP, and Citadel Securities GP LLC each beneficially own 60,572 shares, constituting 0.3% of the class.
- The reported percentages are based on 22,012,924 shares outstanding, which includes 20,712,924 shares outstanding as of September 29, 2025, and 1,300,000 shares issuable upon conversion of certain warrants held by affiliates of the reporting persons.
- The Reporting Persons certify that the securities were not acquired and are not held for the purpose of changing or influencing control of Nano Labs Ltd.
Sentiment
Score: 5
Explanation: Neutral, as this is a factual disclosure of beneficial ownership without commentary on company performance or future prospects.
Future Outlook
NA
Industry Context
NA
Stakeholder Impact
- Shareholders: The disclosure of a significant institutional investor's stake by Citadel may be viewed positively as a vote of confidence in Nano Labs Ltd, potentially influencing investor sentiment.
Key Dates
| Date | Description |
|---|---|
| 2025-09-29 | Date of shares outstanding calculation (20,712,924 shares) |
| 2025-09-30 | Date of event which requires filing of this statement |
| 2025-11-14 | Filing date of Schedule 13G Amendment No. 1 |
Keywords
Nano Labs Ltd, Citadel, Kenneth Griffin, Schedule 13G, beneficial ownership, Class A ordinary shares, warrants, institutional investment, SEC filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.